Geneoscopy Overview
Latest Deal Type
Series A
Latest Deal Amount
$7.95M
Geneoscopy General Information
Description
Developer of next generation diagnostics designed to treat digestive diseases and also offer cancer screening services. The company's diagnostics helps in consistently extract stool-derived eukaryotic RNA (seRNA) transcripts and detect changes in gene expression, enabling doctors to better prevent, detect and guide treatment for gastrointestinal disease.
Geneoscopy Timeline
Want to dig into this profile?
We’ll help you find what you need
Learn more
Geneoscopy Valuation & Funding
| Deal Type |
Date |
Amount |
Raised to Date |
Post-Val |
Status |
Stage |
| 7. Early Stage VC (Series A) |
18-Sep-2019 |
$7.95M |
00.000 |
|
Completed |
Generating Revenue |
| 6. Early Stage VC |
29-Nov-2016 |
000 |
00.000 |
|
Completed |
Startup |
| 5. Grant |
15-Nov-2016 |
0000 |
000.00 |
|
Completed |
Startup |
| 4. Grant |
01-Jan-2016 |
0000 |
000.00 |
|
Completed |
Startup |
| 3. Seed Round |
|
|
000.00 |
|
Completed |
Startup |
| 2. Accelerator/Incubator |
|
|
$22.6K |
|
Completed |
Startup |
| 1. Capitalization |
01-Jan-2015 |
$22.6K |
$22.6K |
|
Completed |
Startup |
Geneoscopy Executive Team (4)
| Name |
Title |
Board Seat |
Contact Info |
| Andrew Barnell |
Co-Founder, Chief Executive Officer, Chief Financial Officer & Board Member |
|
|
| Yiming Kang Ph.D |
Co-Founder & Chief Technology Officer |
|
|
| Erica Barnell Ph.D |
Co-Founder & Chief Scientific Officer |
|
|
1 Former Executive